Clinical Trial Update: A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase II study exploring safety and efficacy of E7820 plus cetuximab in advanced colorectal cancer; run-in study in advanced solid tumors completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• E7820

Snippet

Sponsor: Eisai Inc. | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: COMPLETED